tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Value
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Smart Value
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

LLY Stock Latest News

Hims & Hers Health (HIMS) Shares Spike with Compounded Drug Strategy for GLP-1s
Market NewsHims & Hers Health (HIMS) Shares Spike with Compounded Drug Strategy for GLP-1s
1d ago
LLY
NVO
China Highlights Business Opportunities to America’s Apple (AAPL) and Pfizer
PremiumMarket News
China Highlights Business Opportunities to America’s Apple (AAPL) and Pfizer
1d ago
MA
GLW
J&J (JNJ) Commits $55B to U.S. Manufacturing Expansion as Trump’s Tariffs Pressure Mounts
PremiumMarket News
J&J (JNJ) Commits $55B to U.S. Manufacturing Expansion as Trump’s Tariffs Pressure Mounts
4d ago
JNJ
LLY
Accenture reports Q2 beat, Apple TV+ losing $1B annually: Morning Buzz
PremiumThe Fly
Accenture reports Q2 beat, Apple TV+ losing $1B annually: Morning Buzz
5d ago
YY
ACN
Eli Lilly launches weight-loss drug Mounjaro in India, Reuters says
PremiumThe Fly
Eli Lilly launches weight-loss drug Mounjaro in India, Reuters says
5d ago
LLY
NVO
Hims & Hers to keep offering compounded Ozempic, Wegovy, WSJ reports
PremiumThe FlyHims & Hers to keep offering compounded Ozempic, Wegovy, WSJ reports
5d ago
LLY
NVO
Eli Lilly (LLY) Leads India’s Weight-Loss Drug Race with Mounjaro
Premium
Market News
Eli Lilly (LLY) Leads India’s Weight-Loss Drug Race with Mounjaro
5d ago
LLY
NVO
Hims & Hers’ Weight-Loss Empire Hits a Gut-Wrenching Barrier
Premium
Market News
Hims & Hers’ Weight-Loss Empire Hits a Gut-Wrenching Barrier
6d ago
LLY
NVO
3 Best Growth Stocks to Buy Now, 3/19/2025, According to Analysts 
PremiumMarket News
3 Best Growth Stocks to Buy Now, 3/19/2025, According to Analysts 
6d ago
LLY
LYV
Trump Trade: Administration explores simplified plans for reciprocal tariffs
PremiumThe Fly
Trump Trade: Administration explores simplified plans for reciprocal tariffs
7d ago
X
MS
Big pharma fears drug price spikes in US-EU tariff spat, Reuters says
PremiumThe Fly
Big pharma fears drug price spikes in US-EU tariff spat, Reuters says
7d ago
AZN
BMY
Oppenheimer biotech analyst holds an analyst/industry conference call
PremiumThe Fly
Oppenheimer biotech analyst holds an analyst/industry conference call
8d ago
AZN
LLY
Positive Outlook for Eli Lilly & Co. Amid FDA Support and Strong Revenue Projections
PremiumRatingsPositive Outlook for Eli Lilly & Co. Amid FDA Support and Strong Revenue Projections
8d ago
LLY
FDA voices ‘concerns’ with unapproved GLP-1 drugs used for weight loss
Premium
The Fly
FDA voices ‘concerns’ with unapproved GLP-1 drugs used for weight loss
8d ago
LLY
NVO
Citi sees positive read-through to Lilly shares on FDA GLP-1 statement
Premium
The Fly
Citi sees positive read-through to Lilly shares on FDA GLP-1 statement
8d ago
LLY
Eli Lilly’s Promising Position in Weight Management Market Drives Buy Rating
PremiumRatings
Eli Lilly’s Promising Position in Weight Management Market Drives Buy Rating
12d ago
LLY
Giftify reports 916% w/w increase in pharmacy retailer gift cards sold
PremiumThe Fly
Giftify reports 916% w/w increase in pharmacy retailer gift cards sold
13d ago
LLY
NVO
Eli Lilly & Co: Promising CagriSema Performance Justifies Buy Rating Despite Tolerability Concerns
PremiumRatings
Eli Lilly & Co: Promising CagriSema Performance Justifies Buy Rating Despite Tolerability Concerns
14d ago
LLY
Citi Sticks to Sell Rating on Hims & Hers (HIMS) Stock as FDA Ruling Clouds Outlook
PremiumMarket News
Citi Sticks to Sell Rating on Hims & Hers (HIMS) Stock as FDA Ruling Clouds Outlook
14d ago
LLY
HIMS
Novo Nordisk (NVO) Sinks after Weight-Loss Drug Trial Misses Expectations
PremiumMarket NewsNovo Nordisk (NVO) Sinks after Weight-Loss Drug Trial Misses Expectations
15d ago
LLY
NVO
Novo Nordisk under pressure as obesity drug disappoints in diabetes trial
Premium
The Fly
Novo Nordisk under pressure as obesity drug disappoints in diabetes trial
15d ago
LLY
NVO
Morgan Stanley says REDEFINE-2 misses opportunity to differentiate in diabetes
Premium
The Fly
Morgan Stanley says REDEFINE-2 misses opportunity to differentiate in diabetes
15d ago
LLY
NVO

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >